TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 4 | 6 | 5 | 17 | 132 | 190 | 165 | 86 |
| S | %wins | 0 | 25 | 25 | 25 | 25 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/25/16 17:44 | 5/23/16 | PZRX | Phaserx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gillis Steven | IL | DT | S.d | -7 | 0.0100 | 1 | -680 | -19 | 2,864 | I | -2 | 14 | 9 | -6 | -37 | -74 | |||||||||
10/14/14 17:07 | 10/9/14 | BLUE | Bluebird Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gillis Steven | IL | D | S | -4,054 | 35.25 | 12 | -115 | -10 | 1,041 | I | 37 | 46 | -6 | -20 | -15 | -12 | -13 | 5 | 19 | 35 | 225 | 330 | 163 | ||
10/7/14 17:34 | 10/3/14 | BLUE | Bluebird Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gillis Steven | IL | D | S.m | -2,035 | 35.43 | 12 | -57 | -5 | 1,156 | I | 35 | 63 | 2 | -5 | -1 | -2 | 1 | 3 | -11 | 21 | 174 | 261 | 173 | ||
10/2/14 17:43 | 9/30/14 | BLUE | Bluebird Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gillis Steven | IL | D | S.m | -3,216 | 35.28 | 13 | -91 | -7 | 1,214 | I | 28 | 50 | -11 | -6 | -5 | -5 | -6 | 3 | 1 | 19 | 164 | 242 | 158 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |